Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis

English version České info

Background:
Hepatic dysfunction and jaundice are traditionally viewed as late features of sepsis and portend poor outcomes. We hypothesized that changes in liver function occur early in the onset of sepsis, yet pass undetected by standard laboratory tests.

Methods and Findings:
In a long-term rat model of faecal peritonitis, biotransformation and hepatobiliary transport were impaired, depending on subsequent disease severity, as early as 6 h after peritoneal contamination. Phosphatidylinositol-3-kinase (PI3K) signalling was simultaneously induced at this time point. At 15 h there was hepatocellular accumulation of bilirubin, bile acids, and xenobiotics, with disturbed bile acid conjugation and drug metabolism. Cholestasis was preceded by disruption of the bile acid and organic anion transport machinery at the canalicular pole. Inhibitors of PI3K partially prevented cytokine-induced loss of villi in cultured HepG2 cells. Notably, mice lacking the PI3Kγ gene were protected against cholestasis and impaired bile acid conjugation. This was partially confirmed by an increase in plasma bile acids (e.g., chenodeoxycholic acid [CDCA] and taurodeoxycholic acid [TDCA]) observed in 48 patients on the day severe sepsis was diagnosed; unlike bilirubin (area under the receiver-operating curve: 0.59), these bile acids predicted 28-d mortality with high sensitivity and specificity (area under the receiver-operating curve: CDCA: 0.77; TDCA: 0.72; CDCA+TDCA: 0.87).

Conclusions:
Liver dysfunction is an early and commonplace event in the rat model of sepsis studied here; PI3K signalling seems to play a crucial role. All aspects of hepatic biotransformation are affected, with severity relating to subsequent prognosis. Detected changes significantly precede conventional markers and are reflected by early alterations in plasma bile acids. These observations carry important implications for the diagnosis of liver dysfunction and pharmacotherapy in the critically ill. Further clinical work is necessary to extend these concepts into clinical practice.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis. PLoS Med 9(11): e32767. doi:10.1371/journal.pmed.1001338
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001338

Souhrn

Zdroje

1. WhiteheadMW, HainsworthI, KinghamJG (2001) The causes of obvious jaundice in South West Wales: perceptions versus reality. Gut 48: 409–413.

2. KramerL, JordanB, DrumlW, BauerP, MetnitzPG (2007) Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med 35: 1099–1104.

3. VanwijngaerdenYM, WautersJ, LangoucheL, Vander PerreS, LiddleC, et al. (2011) Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 54: 1741–1752.

4. ChaudryIH, SchleckS, ClemensMG, KupperTE, BaueAE (1982) Altered hepatocellular active transport. An early change in peritonitis. Arch Surg 117: 151–157.

5. MoseleyRH (1997) Sepsis-associated cholestasis. Gastroenterology 112: 302–306.

6. GeierA, FickertP, TraunerM (2006) Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3: 574–585.

7. BrownKA, BrainSD, PearsonJD, EdgeworthJD, LewisSM, et al. (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet 368: 157–169.

8. LaschkeMW, MengerMD, WangY, LindellG, JeppssonB, et al. (2007) Sepsis-associated cholestasis is critically dependent on P-selectin-dependent leukocyte recruitment in mice. Am J Physiol Gastrointest Liver Physiol 292: G1396–G1402.

9. GeierA, DietrichCG, VoigtS, KimSK, GerloffT, et al. (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345–354.

10. TraunerM, FickertP, StauberRE (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14: 946–959.

11. Oude ElferinkRP, JansenPL (1994) The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics. Pharmacol Ther 64: 77–97.

12. CullenDJ, SweitzerBJ, BatesDW, BurdickE, EdmondsonA, et al. (1997) Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 25: 1289–1297.

13. BarberisL, HirschE (2008) Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Thromb Haemost 99: 279–285.

14. VenableJD, AmeriksMK, BlevittJM, ThurmondRL, Fung-LeungWP (2010) Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease. Recent Pat Inflamm Allergy Drug Discov 4: 1–15.

15. BoaglioAC, ZucchettiAE, Sanchez PozziEJ, PellegrinoJM, OchoaJE, et al. (2010) Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17beta-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C. Hepatology 52: 1465–1476.

16. MisraS, UjhazyP, GatmaitanZ, VarticovskiL, AriasIM (1998) The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem 273: 26638–26644.

17. GuicciardiME, GoresGJ (2002) Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease. Dig Liver Dis 34: 387–392.

18. BrunkhorstFM, EngelC, BloosF, Meier-HellmannA, RagallerM, et al. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358: 125–139.

19. ReinhartK, BrunkhorstFM, BoneHG, BardutzkyJ, DempfleCE, et al. (2010) [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]. Anaesthesist 59: 347–370.

20. DysonA, RudigerA, SingerM (2011) Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med 37: 1192–2000.

21. GonnertFA, RecknagelP, SeidelM, JbeilyN, DahlkeK, et al. (2011) Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. J Surg Res 170: e123–e134.

22. RudigerA, DysonA, FelsmannK, CarréJE, TaylorV, et al. (2012) Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis. Clin Sci (Lond) E-pub ahead of print. doi:10.1042/CS20120334.

23. FickertP, WagnerM, MarschallHU, FuchsbichlerA, ZollnerG, et al. (2006) 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130: 465–481.

24. RecknagelP, ClausRA, NeugebauerU, BauerM, GonnertFA (2012) In vivo imaging of hepatic excretory function in the rat by fluorescence microscopy. J Biophotonics 5: 571–581.

25. HirschE, KatanaevVL, GarlandaC, AzzolinoO, PirolaL, et al. (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: 1049–1053.

26. GonnertFA, KunischE, GajdaM, LambeckS, WeberM, et al. (2012) Hepatic fibrosis in a long-term murine model of sepsis. Shock 37: 399–407.

27. WestermannM, SteinigerF, RichterW (2005) Belt-like localisation of caveolin in deep caveolae and its re-distribution after cholesterol depletion. Histochem Cell Biol 123: 613–620.

28. AitioA (1978) A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem 85: 488–491.

29. KlingerW, MüllerD (1977) Ethylmorphine-N-demethylation by liver homogenate of newborn and adult rats; enzyme kinetics and age course of Vmax and Km1. Acta Biol Med Ger 36: 1149–1159.

30. HabigWH, PabstMJ, JakobyWB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139.

31. BurchellB (1981) Bilirubin UDPglucuronyltransferase. Methods Enzymol 77: 188–192.

32. KrafftC, DiderhoshanMA, RecknagelP, MiljkovicM, BauerM, et al. (2011) Crisp and soft multivariate methods visualize individual cell nuclei in Raman images of liver tissue sections. Vib Spectrosc 55: 90–100.

33. DuP, KibbeWA, LinSM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547–1548.

34. StoreyJD, TibshiraniR (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440–9445.

35. HuangL, VoreM (2001) Multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green. Drug Metab Dispos 29: 634–637.

36. StylesNA, FalanyJL, BarnesS, FalanyCN (2007) Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver. J Lipid Res 48: 1305–1315.

37. MolnarRG, WangP, AyalaA, GaneyPE, RothRA, et al. (1997) The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res 73: 117–122.

38. WeberM, LambeckS, DingN, HenkenS, KohlM, et al. (2012) Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB J 26: 2424–2436.

39. BeigneuxAP, MoserAH, ShigenagaJK, GrunfeldC, FeingoldKR (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275: 16390–16399.

40. KimMS, ShigenagaJ, MoserA, FeingoldK, GrunfeldC (2003) Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278: 8988–8995.

41. van MalensteinH, WautersJ, MesottenD, LangoucheL, De VosR, et al. (2010) Molecular analysis of sepsis-induced changes in the liver: microarray study in a porcine model of acute fecal peritonitis with fluid resuscitation. Shock 34: 427–436.

42. ChandN, SanyalAJ (2007) Sepsis-induced cholestasis. Hepatology 45: 230–241.

43. TraunerM, BoyerJL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83: 633–671.

44. KubitzR, WettsteinM, WarskulatU, HaussingerD (1999) Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116: 401–410.

45. TraunerM, ArreseM, SorokaCJ, AnanthanarayananM, KoeppelTA, et al. (1997) The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113: 255–264.

46. HaussingerD, SchmittM, WeiergraberO, KubitzR (2000) Short-term regulation of canalicular transport. Semin Liver Dis 20: 307–321.

47. TraunerM, MeierPJ, BoyerJL (1998) Molecular pathogenesis of cholestasis. N Engl J Med 339: 1217–1227.

48. SathirakulK, SuzukiH, YasudaK, HananoM, TagayaO, et al. (1993) Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. J Pharmacol Exp Ther 265: 1301–1312.

49. DonnerMG, WarskulatU, SahaN, HaussingerD (2004) Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385: 331–339.

50. ArundelC, LewisJH (2007) Drug-induced liver disease in 2006. Curr Opin Gastroenterol 23: 244–254.

51. KrugerPS, FreirNM, VenkateshB, RobertsonTA, RobertsMS, et al. (2009) A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med 35: 717–721.

52. CarcilloJA, DoughtyL, KofosD, FryeRF, KaplanSS, et al. (2003) Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med 29: 980–984.

53. TraunerM, ClaudelT, FickertP, MoustafaT, WagnerM (2010) Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28: 220–224.

54. HohenesterS, GatesA, WimmerR, BeuersU, AnwerMS, et al. (2010) Phosphatidylinositol-3-kinase p110gamma contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells. J Hepatol 53: 918–926.

55. MisraS, UjhazyP, VarticovskiL, AriasIM (1999) Phosphoinositide 3-kinase lipid products regulate ATP-dependent transport by sister of P-glycoprotein and multidrug resistance associated protein 2 in bile canalicular membrane vesicles. Proc Natl Acad Sci U S A 96: 5814–5819.

56. PerezMJ, BrizO (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15: 1677–1689.

57. BeuersU, DenkGU, SorokaCJ, WimmerR, RustC, et al. (2003) Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J Biol Chem 278: 17810–17818.

58. RustC, BauchmullerK, FickertP, FuchsbichlerA, BeuersU (2005) Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. Am J Physiol Gastrointest Liver Physiol 289: G88–G94.

59. SchoemakerMH, Conde de la RosaL, Buist-HomanM, VrenkenTE, HavingaR, et al. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563–1573.